| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.27 | 6e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |